Fernanda Führ

Gemifloxacin mesylate (GFM) stability evaluation applying a validated bioassay method and in vitro cytotoxic study.

N. Nardi, A. Barth, M. Steppe, 2011, Talanta.

Structural elucidation of gemifloxacin mesylate degradation product.

Cássia V Garcia, M. Steppe, C. S. Paim, 2016, Biomedical chromatography : BMC.

Simultaneous analysis of gemifloxacin mesylate and its main synthetic impurity by an optimized capillary zone electrophoretic method

M. Steppe, C. S. Paim, Fernanda Führ, 2014 .

Stability-Indicating LC Assay and Determination of System Suitability Limits with a Robustness Test of Gemifloxacin Mesylate in Tablets

M. Steppe, C. S. Paim, Fernanda Führ, 2010 .

Highly selective colorimetric method to determine gemifloxacin mesylate in the presence of a synthetic impurity.

M. Steppe, C. S. Paim, Fernanda Führ, 2014, Journal of AOAC International.